Movement Alert｜CSPC Pharmaceutical Rises 3.19% in Regular Trading, Pharmaceutical Sector Strengthens Amid Dense Positive Catalysts

Market Focus

Jul 10

On July 10, CSPC Pharmaceutical rose 3.19% in regular trading, trading at 8.14 HKD/share, with turnover of HKD 219 million. The move came as the broader pharmaceutical sector rallied alongside a cluster of recent company-specific catalysts.

On the news front, CSPC recently announced a strategic collaboration with AstraZeneca on siRNA drug discovery and extrahepatic targeted delivery platforms, with a deal valued at up to USD 1.77 billion, including a USD 30 million upfront payment. Additionally, the company's ADC drug SYS6043 was granted breakthrough therapy designation by China's NMPA for platinum-resistant ovarian cancer. Subsidiary CSPC Innovation also resubmitted its Hong Kong listing application on June 18.

At the sector level, pharmaceutical stocks broadly strengthened, with Asymchem up 5.64%, Hengrui Pharma up 3.33%, Hansoh Pharma up 2.82%, and Luye Pharma up 1.57%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1131205551"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1131205551\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1131205551?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-10 10:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1131205551","market":"us","top_or_hot":-1,"title":"Movement Alert｜CSPC Pharmaceutical Rises 3.19% in Regular Trading, Pharmaceutical Sector Strengthens Amid Dense Positive Catalysts","media":"Market Focus","content":"<p><p>On July 10, CSPC Pharmaceutical rose 3.19% in regular trading, trading at 8.14 HKD/share, with turnover of HKD 219 million. The move came as the broader pharmaceutical sector rallied alongside a cluster of recent company-specific catalysts.</p><p>On the news front, CSPC recently announced a strategic collaboration with AstraZeneca on siRNA drug discovery and extrahepatic targeted delivery platforms, with a deal valued at up to USD 1.77 billion, including a USD 30 million upfront payment. Additionally, the company's ADC drug SYS6043 was granted breakthrough therapy designation by China's NMPA for platinum-resistant ovarian cancer. Subsidiary CSPC Innovation also resubmitted its Hong Kong listing application on June 18.</p><p>At the sector level, pharmaceutical stocks broadly strengthened, with Asymchem up 5.64%, Hengrui Pharma up 3.33%, Hansoh Pharma up 2.82%, and Luye Pharma up 1.57%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜CSPC Pharmaceutical Rises 3.19% in Regular Trading, Pharmaceutical Sector Strengthens Amid Dense Positive Catalysts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜CSPC Pharmaceutical Rises 3.19% in Regular Trading, Pharmaceutical Sector Strengthens Amid Dense Positive Catalysts\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-10 10:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 10, CSPC Pharmaceutical rose 3.19% in regular trading, trading at 8.14 HKD/share, with turnover of HKD 219 million. The move came as the broader pharmaceutical sector rallied alongside a cluster of recent company-specific catalysts.</p><p>On the news front, CSPC recently announced a strategic collaboration with AstraZeneca on siRNA drug discovery and extrahepatic targeted delivery platforms, with a deal valued at up to USD 1.77 billion, including a USD 30 million upfront payment. Additionally, the company's ADC drug SYS6043 was granted breakthrough therapy designation by China's NMPA for platinum-resistant ovarian cancer. Subsidiary CSPC Innovation also resubmitted its Hong Kong listing application on June 18.</p><p>At the sector level, pharmaceutical stocks broadly strengthened, with Asymchem up 5.64%, Hengrui Pharma up 3.33%, Hansoh Pharma up 2.82%, and Luye Pharma up 1.57%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01093","symbol_name":"石药集团","start_time":0,"source_url":"","article_id":"1131205551","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1131205551","pubTimestamp":1783649165,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 10, CSPC Pharmaceutical rose 3.19% in regular trading, trading at 8.14 HKD/share, with turnover of HKD 219 million. The move came as the broader pharmaceutical sector rallied alongside a...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01093":"石药集团"},"translate_title":"走势提醒|石药集团常规交易上涨3.19%，医药板块在密集利好催化剂下走强","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01093":1},"content_text":"On July 10, CSPC Pharmaceutical rose 3.19% in regular trading, trading at 8.14 HKD/share, with turnover of HKD 219 million. The move came as the broader pharmaceutical sector rallied alongside a cluster of recent company-specific catalysts.On the news front, CSPC recently announced a strategic collaboration with AstraZeneca on siRNA drug discovery and extrahepatic targeted delivery platforms, with a deal valued at up to USD 1.77 billion, including a USD 30 million upfront payment. Additionally, the company's ADC drug SYS6043 was granted breakthrough therapy designation by China's NMPA for platinum-resistant ovarian cancer. Subsidiary CSPC Innovation also resubmitted its Hong Kong listing application on June 18.At the sector level, pharmaceutical stocks broadly strengthened, with Asymchem up 5.64%, Hengrui Pharma up 3.33%, Hansoh Pharma up 2.82%, and Luye Pharma up 1.57%.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}